Living healthy on a dying planet—we are a world out of balance. Relying on science to improve the health of the individual with the design of new drugs and therapies, we are neglectful of the health of our humanity at a global level. Disease indeed does compromise humankind’s very existence … but it is not disease inflicted on humans … rather it is the disease inflicted by humans on our planet and the response of its immunological system on us. Climate change continues to outpace the implementation of renewable energy at an alarming rate.

Gadolinium-based contrast agents (GBCAs) are widely used in magnetic resonance imaging (MRI) to improve tissue visualization and lesion detection. Despite their widespread clinical use, conventional GBCAs still face important limitations, including relatively low relaxivity and safety concerns associated with gadolinium release and retention. Therefore, the development of next-generation GBCAs requires molecular designs that improve imaging performance while maintaining high stability and minimizing gadolinium exposure.